DNA-PK inhibitor peposertib enhances p53-dependent cytotoxicity of DNA double-strand break inducing therapy in acute leukemia

Peposertib (M3814) is a potent and selective DNA-PK inhibitor in early clinical development. It effectively blocks non-homologous end-joining repair of DNA double-strand breaks (DSB) and strongly potentiates the antitumor effect of ionizing radiation (IR) and topoisomerase II inhibitors. By suppress...

Descripción completa

Detalles Bibliográficos
Autores principales: Haines, Eric, Nishida, Yuki, Carr, Michael I., Montoya, Rafael Heinz, Ostermann, Lauren B., Zhang, Weiguo, Zenke, Frank T., Blaukat, Andree, Andreeff, Michael, Vassilev, Lyubomir T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8190296/
https://www.ncbi.nlm.nih.gov/pubmed/34108527
http://dx.doi.org/10.1038/s41598-021-90500-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8190296/
https://www.ncbi.nlm.nih.gov/pubmed/34108527
http://dx.doi.org/10.1038/s41598-021-90500-3

Ejemplares similares